Perspectives

The importance of patient empowerment

Patient perspectives in myeloma care: importance and incorporation

CAR-T in myeloma: what is the potential?

Daratumumab practical considerations in MM

HARMONY project: an overview

Health technology assessments

The regulation of personalized medicine trials

Upcoming updates in multiple myeloma

Induction in myeloma: a journey over time

Current affairs: opinion on quizartinib approval status in AML

New horizons in CML

Brian Koffman on CLL: personal to professional

Update on hematology work in Oxford

Mantle cell lymphoma update: changing times & latest news

Does chemotherapy still have a role in the treatment of Waldenström’s?

Chemo-free in CLL not always the best option